Potentially Inappropriate Medications in Elderly Patients: Prevalence at Admission and Changes During Hospital Stay
|
|
- Megan Warren
- 5 years ago
- Views:
Transcription
1 Potentially Inappropriate Medications in Elderly Patients: Prevalence at Admission and Changes During Hospital Stay
2 Background
3 Polypharmacy in the Elderly 40% seniors are using 5-9 different classes of medications 15% 85+ using 15+ medication classes Drug Use Among Seniors on Public Drug Programs in Canada. CIHI 2014
4 Adverse Drug Events in Elderly 20% of all hospitalizations in elderly related to severe ADE s= cost of $36 million / year in Canada 35% community dwelling elderly=1 ADE/ year
5 Potentially Inappropriate Medication Use in the Elderly 10-15% of seniors use inappropriate medications Drug Use Among Seniors on Public Drug Programs in Canada. CIHI 2014
6 Objective Estimate the prevalence of potentially inappropriate CNS medications upon admission and describe changes made during the hospital stay among patients 65 years of age and older
7 Methods
8 Data Sources & Measured Variables Community Drug List Discharge Prescription Patient demographics, health care service utilization, drug dispensations 1 year Hospital stay Admission to Hospital Discharge from Hospital RAMQ Health Services & Prescription Claims Electronic Medication Reconciliation software
9 Electronic Medication Reconciliation Software- Right Rx Provincial Drug Repository & Master Provider Registry Hospital Pharmacy System Side by side view of community and hospital medications Standardized, printable, barcoded forms across institutions Alignment of matching medications Meets all Accreditation Canada requirements
10 Electronic Medication Reconciliation Software- Right Rx
11 Example of Patient Drug Changes Drug A Drug A STOP Drug B NEW Drug C Drug C MODIFY Drug D Drug D CONTINUE Drugs present at admission In hospital medications Drug changes at discharge
12 Discharge Prescription Total number of medications continued from the community=5 Total number of community medications stopped=1 Total number of new medications=7 Total number of medications at discharge= 12
13 Study cohort Admitted to MG & RVH 1 October February years of age Admitted from community or long term care Intervention patients with finalized e-prescription At least 1 CNS PIM 1 year Hospital stay Continuous RAMQ coverage Admission to Hospital N=2,328 patients Discharge from Hospital N=194 patients
14 Identification of Potentially Inappropriate Central Nervous System Medications- Modified STOPP Criteria Prolonged use of benzodiazepines (> 4 weeks) Prolonged use of antipsychotics (> 4 weeks) Prolonged use of TCA s (> 4 weeks) Use of first-generation antihistamines
15 Cohort Characteristics 2,328 patients Mean age 77 (SD 8) 44% female 67% 2+ chronic conditions 18% 7+ unique prescribers in year prior to admission 23% visiting more than 1 unique pharmacy in year prior to admission 9 medications on average per patient
16 CNS PIMs Present at Admission 5% 1% 650/2,328 (28%) patients had at least 1 CNS PIM =total of 628 CNS PIMs 22% Number of CNS PIMS per patient 72% 0 PIMs 1 PIM 2 PIMs 3+ PIMs
17 Predicting Presence of CNS PIMs at Admission No PIMs (n=1678) At least one PIM (n=650) Adjusted OR Male 1014 (77.0) 303 (23.0) Reference Female 664 (65.7) 347 (34.3) 1.69 ( ) Number of distinct pharmacies prior to admission, mean(sd) 1.4 (0.74) 1.5 (0.82) 1.17 ( ) (100) 0 (-) (72.0) 400 (28.1) (67.8) 250 (38.5) (8.2) 225 (34.6) Number of distinct prescribers prior to admission, mean (SD) 4.3 (3.4) 5.8 (3.6) 0.98 ( ) (84.9) 101 (15.1) (69.6) 378 (30.4) (59.1) 171 (40.1) Number of chronic conditions, mean (SD) 2.2 (2.7) 2.7 (3.0) 1.03 ( ) (74.3) 188 (25.8) (74.6) 109 (25.4) (72.9) 118 (27.1) (30.0) 235 (36.2) Number of admission medications, mean (SD) 8.1 (5.6) 12.6 (5.6) 1.15 ( ) (93.8) 33 (6.3) (76.5) 174 (23.5) (62.8) 227 (37.2) (52.6) 216 (47.4)
18 Classes of CNS PIMs Present at Admission 4% 7% Benzodiazepines Antipsychotics Antihistamines 31% 58% TCA's
19 Changes made to CNS PIMs Present at Admission All CNS PIMs Benzodiazepines Antipsychotics Antihistamines Stop Modify Continue TCA's Percent of Reconciliation Actions
20 True Stops and Therapeutic Substitutions All CNS PIMs Benzodiazepines Antipsychotics Antihistamines True stop Therapeutic substitution Modify Continue TCA's Percent of Reconciliation Actions
21 Conclusions & Future Research
22 Conclusions High prevalence treatment with CNS PIMs at admission Benzodiazepines most common Majority of CNS PIMs not discontinued during hospitalization Demonstrates usability of data from electronic medication reconciliation software
23 Next steps Determine prevalence of all STOPP medications at admission Evaluate patient, physician and system level factors associated with deprescribing of PIMs Determine whether de-prescription of PIMs associated with improved health outcomes post-discharge
24 Acknowledgements Co-authors Dr. Robyn Tamblyn Dr. Aude Motulsky Dr. Todd Lee Maria- Teresa Moraga Funding Source Canadian Institutes of Health Research Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
25 Thank you! Daniala Weir PhD candidate Department of Epidemiology, Biostatistics and Occupational Health McGill University
Robyn Tamblyn, BSCN MSc PhD May 2 nd, 2018 Baldwin Seminar Series Accreditation Council for Graduate Medical Education
Robyn Tamblyn, BSCN MSc PhD May 2 nd, 2018 Baldwin Seminar Series Accreditation Council for Graduate Medical Education Robyn Tamblyn, BScN, MSc, PhD, CM Disclosure None of the above speakers have any conflicts
More informationThe STOPP/START Criteria: International Synthesis and Local Contextualization
The STOPP/START Criteria: International Synthesis and Local Contextualization Presented November 21, 2014 to TVN MindMerge TVN Improving care for the frail elderly Barbara Hill-Taylor IMPART, College of
More informationIMPROVING MEDICATION SAFETY AMONG ELDERLY PATIENTS IN AN AMBULATORY SETTING. Alyssa Berry, Rebecca Burgett, Erin Day, Aron Hrubetz
IMPROVING MEDICATION SAFETY AMONG ELDERLY PATIENTS IN AN AMBULATORY SETTING Alyssa Berry, Rebecca Burgett, Erin Day, Aron Hrubetz Improving Medication Safety Among Elderly Patients in an Ambulatory Setting
More informationPolypharmacy. A CPPE distance learning programme
A CPPE distance learning programme DLP 177 January 2016 Contents About CPPE distance learning programmes About this learning programme Glossary of key terms v vii ix Contents Section 1 The problem with
More informationIatrogenesis in the frail elderly
Iatrogenesis in the frail elderly Professor Michael Dooley Director of Pharmacy Alfred Health Professor of Clinical Pharmacy Centre for Medicine Use and Safety Monash University Iatrogenesis in the frail
More informationTITLE: Discontinuation of Benzodiazepines and Other Sedative-Hypnotic Sleep Medication in Hospitalized Patients: Clinical Evidence and Guidelines
TITLE: Discontinuation of Benzodiazepines and Other Sedative-Hypnotic Sleep Medication in Hospitalized Patients: Clinical Evidence and Guidelines DATE: 25 September 2015 RESEARCH QUESTIONS 1. What is the
More informationExposure to potentially inappropriate medications among long-term care residents with cognitive impairment in Ontario:
Exposure to potentially inappropriate medications among long-term care residents with cognitive impairment in Ontario: Is there an association with frailty? Laura Maclagan, Jun Guan, Sima Gandhi, Colleen
More informationScreening tools for elderly patients in primary care
Screening tools for elderly patients in primary care Cristín Ryan 1 Prof. Julia Kennedy 1 Dr. Denis O Mahony 2 Dr. Stephen Byrne 1 Co-Investigator: Dr. Paul Gallagher 2 1 Pharmaceutical Care Research Group,
More informationStronger together - optimizing pharmacotherapy on geriatric wards?
Stronger together - optimizing pharmacotherapy on geriatric wards? Clinicamp FOD 27/4/2018 Dr. Jean-Claude Lemper ( Geriater UZ Brussel) Apr. Julie Hias (ziekenhuisapotheker UZ Leuven) Project College
More informationHA CONVENTION Effectiveness of Pharmacist-led Frail Elderly Medication Service in Acute Geriatric Ward
Effectiveness of Pharmacist-led Frail Elderly Medication Service in Acute Geriatric Ward HA CONVENTION 2017 Candis Chang Pharmacist Department of Pharmacy Ruttonjee and Tang Shiu Kin Hospitals Background
More informationDeconstructing Polypharmacy. Alan B. Douglass, M.D. Director
Deconstructing Polypharmacy Alan B. Douglass, M.D. Director Recognize this patient? Mrs. Brown- 82 years young Active Medical Problems Hypertension Hyperlipidemia Type 2 Diabetes Peripheral edema Osteoarthritis
More informationOptimizing medication in caring for seniors living with frailty: Five perspectives
Optimizing medication in caring for seniors living with frailty: Five perspectives Community Care Shanna Trenaman BScH, BScPharm, MAHSR, ACPR, PhD(student) Project Manager for A Collaborative Intervention
More informationPolypharmacy and Deprescribing for Older People
Polypharmacy and Deprescribing for Older People Sarah Hilmer Head of Department, Clinical Pharmacology and Senior Staff Specialist Aged Care, RNSH Conjoint Professor of Geriatric Pharmacology, Sydney University
More informationComprehensive Research Plan: Inhaled corticosteroids + long-acting beta agonists (ICS+LABA) for the treatment of asthma
Comprehensive Research Plan: Inhaled corticosteroids + long-acting beta agonists (ICS+LABA) for the treatment of asthma Pharmacoepidemiology Unit July 10, 2014 30 Bond Street, Toronto ON, M5B 1W8 www.odprn.ca
More informationOptimizing medication in caring for seniors living with frailty: Five perspectives
Optimizing medication in caring for seniors living with frailty: Five perspectives Long-term care Susan E. Bronskill, PhD Canadian Frailty Network National Conference September 21, 2018 FRAMING-LTC FRAILTY
More informationPolypharmacy. in the Elderly. Lesley Charles, MBChB, CCFP
Polypharmacy in the Elderly Lesley Charles, MBChB, CCFP Associate Professor and Program Director Division of Care of the Elderly Department of Family Medicine, University of Alberta March 06, 2016 1 Faculty/Presenter
More informationDavid Gardner, BSc Pharm, MSc CH&E, PharmD Professor, Department of Psychiatry & College of Pharmacy
David Gardner, BSc Pharm, MSc CH&E, PharmD Professor, Department of Psychiatry & College of Pharmacy It s no dream. Sleep well without sleeping pills. Outline Baby boomers & beyond: medication use Deprescribing
More informationUse of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia
Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia Aine Leen, Kieran Walsh, David O Sullivan, Denis O Mahony, Stephen Byrne, Margaret Bermingham Pharmaceutical Care Research Group,
More information3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:
Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Addolorata
More informationConflict of interest declaration and sources of funding
Potentially Inappropriate Prescribing immediately prior to Long-Term Care admission (PIP in LTC): Validation of tools for their future use across Ontario Bruyère CLRI Webinar March 24 th, 2016 and Bruyère
More informationInnovative Opportunities for Pharmacists in the Evolving World of Healthcare
Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Assistant Clinical
More informationCanadian Seniors: Polypharmacy and Management in Primary Health Care Settings
Canadian Seniors: Polypharmacy and Management in Primary Health Care Settings Ali Moses McKeag Project Lead Primary Health Care Information CAHSPR Date Wednesday May 11, 2011 Time 2:30 3:45 pm Stream F
More informationWebinar Series April 11, 2018
Webinar Series April 11, 2018 Reducing post-discharge potentially inappropriate medications amongst the elderly: a multi-centre electronic deprescribing intervention Todd Lee, MD, MPH, FRCPC McGill University
More informationTrends in Glucocorticoid-Induced Osteoporosis Management Among Seniors in Ontario,
Trends in Glucocorticoid-Induced Osteoporosis Management Among Seniors in Ontario, 1996-2012 Jordan M Albaum 1, Linda E Lévesque 2, Andrea S Gershon 3, Yan Yun Liu 1, Suzanne M Cadarette 1 1 Leslie Dan
More informationMedication Reconciliation On Admission
Medication Reconciliation On Admission Lions Gate Hospital May 15, 2012 Mary Shyng Medication Safety Pharmacist - Coastal Medication Reconciliation Working Definition: a formal, systematic process in which
More informationAbout ISMP Canada. Analysis Outputs: Safety Bulletins. Less is More: An Introduction to Deprescribing. canada.org
Less is More: An Introduction to Deprescribing Lindsay Yoo, BSc, BScPhm, RPh, CDE, CGP, PharmD Medication Safety Analyst, ISMP Canada About ISMP Canada The Institute for Safe Medication Practices Canada
More informationPolypharmacy in the Elderly
Polypharmacy in the Elderly Physiotherapy Alberta Conference September 24 th 2016 Lesley Charles Associate Professor and Program Director Division of Care of the Elderly Department of Family Medicine,
More informationLegemiddelbruk og hoftebrudd
Legemiddelbruk og hoftebrudd Oppsummering av ph.d. GerIT 05.04.16 LIS Marit Stordal Bakken Haraldsplass Diakonale Sykehus U N I V E R S I T Y O F B E R G E N Potentially inappropriate drug use and hip
More informationMina Tadrous, Diana Martins, Zhan Yao, Kimberly Fernandes, Samantha Singh, Nikita Arora, David Juurlink, Muhammad Mamdani and Tara Gomes
Cognitive Enhancers Pharmacoepidemiology Report: FINAL CENSORED Report Mina Tadrous, Diana Martins, Zhan Yao, Kimberly Fernandes, Samantha Singh, Nikita Arora, David Juurlink, Muhammad Mamdani and Tara
More informationLeveraging Partnerships for a Community-Based Fall Prevention Strategy. Central LHIN and York Region Public Health.
Leveraging Partnerships for a Community-Based Fall Prevention Strategy Central LHIN and York Region Public Health October 11, 2017 Presentation Outline Shared Fall Prevention Mandate Home and Community
More informationEvaluation of a Medicaid Psychotropic Drug Management Program in Utah
Evaluation of a Medicaid Psychotropic Drug Management Program in Utah Dominick Esposito James M. Verdier 2008 SAMHSA/CMS Invitational Conference on Medicaid and Mental Health Service/Substance Abuse Treatment
More informationAppropriate prescribing and deprescribing for older people getting it right. Alan Davis Northland District Health Board
Appropriate prescribing and deprescribing for older people getting it right Alan Davis Northland District Health Board Unused returns Potentially inappropriate medication use in the elderly 15% of older
More informationIntegrating INTERACT into Interim Pharmacist Reviews
Integrating INTERACT into Interim Pharmacist Reviews Chad R. Worz, Pharm.D. President, Medication Managers, LLC Adjunct Assistant Professor of Pharmacy Practice, University of Cincinnati, College of Pharmacy
More informationIntroducing ValueOptions Clinical Care Alerts
Introducing ValueOptions Clinical Care Alerts January 2013 Agenda What are Clinical Care Alerts? How does it work? What are the benefits? Questions and Answers 2 The Issue of Poor Medication Adherence
More informationZhao Y Y et al. Ann Intern Med 2012;156:
Zhao Y Y et al. Ann Intern Med 2012;156:560-569 Introduction Fibrates are commonly prescribed to treat dyslipidemia An increase in serum creatinine level after use has been observed in randomized, placebocontrolled
More informationThe Role of Pharmacists achieving international best practice standards and realising key opportunities.
The Role of Pharmacists achieving international best practice standards and realising key opportunities. Dr. Stephen Byrne Senior Lecturer in Clinical Pharmacy & Director of the MSc in Clinical Pharmacy
More informationMedication Management When Caring for Seniors at Home
Medication Management When Caring for Seniors at Home White Paper May 24, 2013 2013 Physician s Choice Private Duty http://private-duty.pchhc.com 1 Proper medication management for seniors who live at
More informationThe University of Mississippi School of Pharmacy
LONG TERM PERSISTENCE WITH ACEI/ARB THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS OF THE 2006-2007 MEDICARE 5% NATIONAL SAMPLE DATA Lokhandwala T. MS, Yang Y. PhD, Thumula V. MS, Bentley J.P.
More informationReduction of High Risk Medications Using A Quality Initiative Perspective
Reduction of High Risk Medications Using A Quality Initiative Perspective Richard Mueller PharmD, MBA, MS, Director of Pharmacy Dianne Hempel BSN, RN Quality Improvement Coordinator Objectives Learn what
More informationJefferson In the News!
Evaluation of a Pharmacist-led Medication Assessment to Identify the Prevalence of Polypharmacy and Potentially Inappropriate Medication (PIM) Use Among Ambulatory Seniors with Cancer Ginah Nightingale,
More informationPOLYPHARMACY. A practical approach to deprescribing in care homes. Care Home Pharmacy Team. Herts Valleys Clinical Commissioning Group
POLYPHARMACY A practical approach to deprescribing in care homes. Care Home Pharmacy Team Herts Valleys Clinical Commissioning Group Neeta Gulhane Specialist Pharmaceutical Advisor Care Homes The Care
More informationAn Overview of a Provincial Appropriateness of Care Initiative: A Provincial Collaborative Supporting Appropriate, Affordable, and Accessible Care
An Overview of a Provincial Appropriateness of Care Initiative: A Provincial Collaborative Supporting Appropriate, Affordable, and Accessible Care John G. Abbott Deputy Minister, Department of Health and
More informationThe Morbidity and Mortality of Kansas Drug Epidemic
The Morbidity and Mortality of Kansas Drug Epidemic Fan Xiong, MPH Senior Epidemiologist Kansas Board of Pharmacy Kansas Data-Driven Prevention Initiative Program Kansas Department of Health and Environment,
More informationShared decision making for stepdown and stopping decisions. Michael R. Gionfriddo Pharm.D, Ph.D Geisinger Center for Pharmacy Innovation and Outcomes
Shared decision making for stepdown and stopping decisions Michael R. Gionfriddo Pharm.D, Ph.D Geisinger Center for Pharmacy Innovation and Outcomes 1 Disclosures I have had travel and lodging paid for
More informationA Primer on Safe Prescribing to the Elderly. Dr. John Puxty
A Primer on Safe Prescribing to the Elderly Dr. John Puxty Learning Objectives Describe an approach to safe prescribing for older patients. Appreciate the significance and causes of Polypharmacy. Identify
More informationFrequency and cost of potentially inappropriate prescribing for older adults: a cross-sectional study
Frequency and cost of potentially inappropriate prescribing for older adults: a cross-sectional study Steven G. Morgan PhD, Jordan Hunt MA, Jocelyn Rioux BSc, Jeffery Proulx BSc, Deirdre Weymann MA, Cara
More informationBC Methadone Maintenance System: Performance Measures 2011/2012 Appendix A: Report Figures and Data
BC Methadone Maintenance System: Performance Measures 2011/2012 Pharmaceutical Services Division & Population and Public Health Division British Columbia Ministry of Health February 2013 You may download
More informationDeprescribing in CKD patients: Is less more? Speaker: Dr. Judith G. Marin, PharmD
2016 Deprescribing in CKD patients: Is less more? Speaker: Dr. Judith G. Marin, PharmD Case Mr. Kid Ney is a 75 y/o patient who has been on dialysis for the last 4 years (PD, then HD). PMHx: HTN, DM,
More informationChanging patterns of sedative use over time in older adults in Ontario
Changing patterns of sedative use over time in older adults in Ontario Andrea Iaboni, MD, DPhil, FRCPC Toronto Rehabilitation Institute University Health Network Faculty/Presenter Disclosure Faculty: Andrea
More informationFrom medicines reconciliation to medicines review. Dr. Fatma Karapinar Hospital pharmacistepidemiologist
From medicines reconciliation to medicines review Dr. Fatma Karapinar Hospital pharmacistepidemiologist Conflict of interest Nothing to disclose Questions Medication review is more important than medicines
More informationPreventing Medication Related Falls
A Team Approach to Deprescribing and Preventing Medication Related Falls Wednesday, February 13 th 2019 Pam Howell THIS WEBINAR IS BEING RECORDED. THE SLIDE DECK AND RECORDING WILL BE EMAILED AFTER THE
More informationPRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas
PRESCRIBING IN THE ELDERLY CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas LEARNING OUTCOMES Medicines Optimisation The effects of aging on health and medicines. Polypharmacy Acute Kidney
More informationMEDICATIONS PRESCRIPTION AT HOSPITAL DISCHARGE IN PATIENTS WITH VALIDATED DIAGNOSIS OF DEMENTIA. Federica Edith Pisa University Hospital Udine
MEDICATIONS PRESCRIPTION AT HOSPITAL DISCHARGE IN PATIENTS WITH VALIDATED DIAGNOSIS OF DEMENTIA Federica Edith Pisa University Hospital Udine BACKGROUND Polypharmacy and psychotropic medication use are
More informationMeasure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety
Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety 2015 PHYSICIAN QUALITY REPTING OPTIONS F INDIVIDUAL MEASURES REGISTRY ONLY DESCRIPTION:
More informationGeriatric Pharmacology
Geriatric Pharmacology Janice Scheufler R.Ph.,PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Objectives List three risk factors for adverse drug events in the elderly Discuss two physiological
More informationFriday and weekend hospital stays: effects on mortality
ERJ Express. Published on May 14, 2014 as doi: 10.1183/09031936.00007714 ORIGINAL ARTICLE IN PRESS CORRECTED PROOF Friday and weekend hospital stays: effects on mortality Samy Suissa 1,2, Sophie Dell Aniello
More informationAround fifteen semi-structured interviews are going to be conducted with specialist physicians of the domains selected for the checklist.
1 SEMI-STRUCTURED INTERVIEW GUIDE THE INTERVIEW PROCESS This interview is intended to create statements of potential interest for a prescription-screening checklist to detect potentially inappropriate
More informationMail Service Pharmacy
Mail Service s At A Glance Disclaimer: reserves the right to update its measures and measure sets to maintain measure relevancy and to remedy any unintended consequences that may arise during implementation.
More informationStark County Safety Council Presentation: Opioid & Anti-Anxiety Medication Use Among Ohio s Injured Workers
Stark County Safety Council Presentation: Opioid & Anti-Anxiety Medication Use Among Ohio s Injured Workers June 11, 2015 John Hanna, R.Ph. BWC, Pharmacy Director 6/24/2015 BWC Pharmacy Program Overview
More informationIMPROVING MEDICATION AND OUTCOMES FOR OLDER FRAIL RESIDENTS OF LONG-TERM CARE FACILITIES
1 IMPROVING MEDICATION AND OUTCOMES FOR OLDER FRAIL RESIDENTS OF LONG-TERM CARE FACILITIES SUSAN E. BRONSKILL, PHD On behalf of FRAILTY AND RECOGNIZING APPROPRIATE MEDICATION USE IN GERIATRICS AND LONG-TERM
More informationValidity of Administrative Claims Data for Real-Time Surveillance
Validity of Administrative Claims Data for Real-Time Surveillance L Example des Données de la RAMQ Comparing Data Sources Data Source Timeliness Survey Primary telephone/ field team; single or repeated
More informationTackling inappropriate polypharmacy in NHS Scotland
Tackling inappropriate polypharmacy in NHS Scotland Francesca Aaen Lead Care Homes Pharmacist - NHS Lanarkshire Heather Harrison - Senior Prescribing Advisor/ Chronic Pain Primary Care Service Development
More informationPrenatal Care of Women Who Give Birth to Children with Fetal Alcohol Spectrum Disorder Are we missing an opportunity for prevention?
Prenatal Care of Women Who Give Birth to Children with Fetal Alcohol Spectrum Disorder Are we missing an opportunity for prevention? Deepa Singal, PhD Candidate 1 Manitoba Centre for Health Policy Manitoba
More informationPolypharmacy and Anticholinergic Burden in Hospitalised Older Patients - A Cross Sectional Audit
INTERNATIONAL JOURNAL of BIOMEDICAL SCIENCE ORIGINAL ARTICLE Polypharmacy and Anticholinergic Burden in Hospitalised Older Patients - A Cross Sectional Audit Joanna Ulley 1, Sakila Sickander 2, Ahmed H.
More informationSupplementary Online Content
Supplementary Online Content Gomes T, Redelmeier DA, Juurlink DN, et al. Opiod dose and risk of road trauma in Canada: a populationbased study. JAMA Intern Med. Published online January 14, 2013. doi:10.1001/2013.jamainternmed.733.
More informationPolypharmacy and Polymorbid Patients: Practical Tips and Tricks
Polypharmacy and Polymorbid Patients: Practical Tips and Tricks November 2, 2013 Faculty/Presenter Disclosure Faculty: Chris Fan-Lun, BScPhm, ACPR, CGP Pharmacist - Geriatric Medicine Clinical Practice
More informationMichelle Greiver Simone Dahrouge Patricia O Brien Donna Manca Marie-Thérèse Lussier
Michelle Greiver Simone Dahrouge Patricia O Brien Donna Manca Marie-Thérèse Lussier University of Toronto Practice Based Research Network Ottawa Practice Enhancement Network Quality & Innovation Program,
More informationby Lisa Sever, BSc PHM, ACPR, CGP, RPh Learning objectives
THE NATIONAL CONTINUING EDUCATION PROGRAM FOR PHARMACY TECHNICIANS 1 CEU ANSWER ONLINE FOR INSTANT RESULTS AT WWW.CANADIANHEALTHCARENETWORK.CA MAY 2017 FREE APPROVED FOR 1 CE UNIT Approved for 1 CE unit
More informationSafe Prescribing of Drugs with Potential for Misuse/Diversion
College of Physicians and Surgeons of British Columbia Safe Prescribing of Drugs with Potential for Misuse/Diversion Preamble This document establishes both professional standards as well as guidelines
More informationAlberta Health. Seasonal Influenza in Alberta Season Summary
Alberta Health Seasonal Influenza in Alberta 217 218 Season Summary September 218 Seasonal Influenza in Alberta, 217-218 Season Summary September 218 Suggested Citation: Government of Alberta. Seasonal
More informationNa#onal Ins#tute for Health Care Management Founda#on Webinar
Na#onal Ins#tute for Health Care Management Founda#on Webinar Blue Cross Blue Shield of Massachuse=s Opioid Safety Management Program Thomas Kowalski, RPh November 2, 2015 National and Local Concern National
More informationDeprescribing Unnecessary Medications: A Four-Part Process
Deprescribing Unnecessary Medications: A Four-Part Process Scott Endsley, MD Fam Pract Manag. 2018;25(3):28-32. Abstract and Introduction Introduction www.medscape.com Ms. Horatio is a 76-year-old patient
More informationOptimising Safe & Appropriate Medicines Use and Deprescribing. Katie Smith, Director, East Anglia Medicines Information Service February 2014
Optimising Safe & Appropriate Medicines Use and Deprescribing Katie Smith, Director, East Anglia Medicines Information Service February 2014 Background Objectives How & why the OSAMU document was developed
More informationTransforming Care for the Elderly
Transforming Care for the Elderly Session 2: Engaging Pharmacists & Interdisciplinary Care Teams to Improve Prescribing of Antipsychotics & to Reduce Polypharmacy January 11, 2017 3 @cfhi_fcass Welcome
More informationFALL PREVENTION AND OLDER ADULTS BURDEN. February 2, 2016
February 2, 2016 FALL PREVENTION AND OLDER ADULTS Each year in Winnipeg, one in three adults over 65 years of age will experience a fall. 1 Approximately one third of people 65 years of age and older and
More informationLeah M Smith, Jay S Kaufman, Erin C Strumpf, Linda E Lévesque
The effect of HPV vaccination on clinical indicators of sexual behaviour in a population-based cohort of adolescent girls: The Ontario Grade 8 HPV Vaccine Cohort Study Leah M Smith, Jay S Kaufman, Erin
More informationDisclosure. The elderly at risk: reducing medications safely to meet life s changes. Relevant financial relationships.
The elderly at risk: reducing medications safely to meet life s changes Barbara Farrell BScPhm, PharmD, FCSHP European Society of Hospital Pharmacists Conference March 2017 Disclosure Relevant financial
More informationZolpidem Is Independently Associated With Increased Risk of Inpatient Falls
ORIGINAL RESEARCH Zolpidem Is Independently Associated With Increased Risk of Inpatient Falls Bhanu Prakash Kolla, MD, MRCPsych 1, Jenna K. Lovely, PharmD, RPh, BCPS 2, Meghna P. Mansukhani, MD 3, Timothy
More informationPROCEDURE REF NO SABP/EXECUTIVE BOARD/0017
PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 NAME OF GUIDELINE REASON FOR GUIDELINE WHAT THE GUIDELINE WILL ACHIEVE? WHO NEEDS TO KNOW ABOUT IT? Medicines Guideline: Hypnotic Medication Compliance with NICE
More informationUse caution in the elderly: review of safe and effective medication use in older patients
Use caution in the elderly: review of safe and effective medication use in older patients John T. Holmes, PharmD, BCPS Assistant Professor of Family Medicine and Pharmacy Practice In support of improving
More informationMedicines Optimisation the opportunities and challenges. Christina Short Medicines Optimisation Project Manager
Medicines Optimisation the opportunities and challenges Christina Short Medicines Optimisation Project Manager The remit:- Clinical Pharmacy input into the Locality Model Proposal: To contract a senior
More informationAlberta WCB Policies & Information
1. What are the objectives of WCB regarding the authorization of prescribed opioid analgesics As part of an overall approach to effective, appropriate claims management, including the provision of and
More informationMedication safety in vulnerable patient groups - Elderly patients -
Woodennature/CC-BY-SA-3.0 http://theintelligence.de Medication safety in vulnerable patient groups - Elderly patients - 20th Congress of EAHP 25-27 March, 2015, Hamburg, Germany Dr. rer. nat. Beate Wickop
More informationRebecca H. Grandy. Bachelor of Science in Biology with Chemistry Minor University of North Carolina at Chapel Hill. Graduated with Distinction
101 Charles Teague Drive Candler, NC 28715 Education June 2009 June 2010 August 2005 May 2009 August 2001 May 2005 (828) 974-2354 rhgrandy@gmail.com ASHP Accredited PGY1 Pharmacy Practice Residency in
More informationReview of Current Literature 4/2/18 POLYPHARMACY IN ASSISTED LIVING EVIDENCE BASED APPROACH
POLYPHARMACY IN ASSISTED LIVING A Evidence Based Approach to Management of Medication Regimen Complexity By Burton Korer, MSN, RN-BC, CPHQ EVIDENCE BASED APPROACH Evidence-based practice (EBP) is the conscientious
More informationApplying Population Health Management to Opiate Prescription Medication Misuse
Applying Population Health Management to Opiate Prescription Medication Misuse Joe Parks, MD National Council Senior Medical Advisor April 13, 2016 My Background Medicaid Director Previously DMH Medical
More informationManaging medicines. in older people
Managing medicines in older people 6 Primary care oversight of prescribing to older people can reduce both inappropriate prescribing and patient risk. By asking specific questions in consultations and
More informationEmpowering Older Adults On Drug Adherence A Collaborative Service Model. Cheng Po-po, Peggy Nurse Consultant (Gerontology) Yan Chai Hospital, KWC, HA
Empowering Older Adults On Drug Adherence A Collaborative Service Model Cheng Po-po, Peggy Nurse Consultant (Gerontology) Yan Chai Hospital, KWC, HA Introduction Older adults have multiple pathologies
More informationPreventing Falls in Older Adults A Matter of Safety
Preventing Falls in Older Adults A Matter of Safety Roger Tam, BSc. Pharm. Wal-Mart Clinical Designated Pharmacist Falls Prevention Pharmacist Specialist NCCHC-Pre/Post Test Educator Q.U.I.T Educator Overview
More informationCanadian Practices for the Treatment of Delirium. Lisa Burry, BScPharm, PharmD
Canadian Practices for the Treatment of Delirium Lisa Burry, BScPharm, PharmD Disclosures & Acknowledgements Conflicts of interest: None Acknowledgements: our patients and the clinical staff that supported
More informationHospital Discharge Data
Hospital Discharge Data West Virginia Health Care Authority Hospitalization data were obtained from the West Virginia Health Care Authority s (WVHCA) hospital discharge database. Data are submitted by
More informationWe asked, you answered
We asked, you answered an innovative method to sourcing answers to pressing health policy and health care questions CAHSPR 2016 Panel Discussion Canada Health Infoway 2016 1 Our Panel Erika Yates Senior
More informationPolypharmacy: Making it all Work Kathy Wilson, RPh, RWSIR Director of Pharmacy
Polypharmacy: Making it all Work Kathy Wilson, RPh, RWSIR Director of Pharmacy Polypharmacy can be defined as the use of multiple medications for the treatment of a patient s medical conditions. The term
More informationThe Importance of Reporting Adverse Drug Reactions and Creating a Culture of Safety. Kristy Malacos Magruder Hospital Pharmacy Systems, Inc.
The Importance of Reporting Adverse Drug Reactions and Creating a Culture of Safety Kristy Malacos Magruder Hospital Pharmacy Systems, Inc. Objectives Describe Adverse Drug Reactions (ADR)and the importance
More informationExecutive Summary. Classes Under Review: Analysis:
Outcome Report on MHQAC Edits Classes Under Review: Analysis: Atypical Antipsychotics, SSRIs, SNRIs, Antianxietals, Hypnotics, and Drugs to Treat ADD/ADHD Utilization and Cost Trends: Pre and Post Implementation
More informationTELUS Health Conference Toronto
TELUS Health Conference Toronto Dr. Wendy Levinson, MD, OC Chair, Choosing Wisely Canada & International Professor of Medicine, University of Toronto March 23rd, 2016 Wedges of Waste 2 I ve always done
More informationSAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND. Sandra Brownstein, PharmD, CGP
SAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND Sandra Brownstein, PharmD, CGP Objectives: List potential medication related problems that increase in the frail elderly with acute illness Differentiate
More informationCanadian Deprescribing Network
Canadian Deprescribing Network 2017 Annual Report 1 What s deprescribing? Deprescribing is the planned and supervised process of reducing or stopping medications that may no longer be of benefit or may
More informationNote: Mandatory measures are those measures that are a requirement of accreditation and must be reported to URAC on an annual basis.
COMMUNITY PHARMACY V1.1 MANDATORY S Note: Mandatory measures are those measures that are a requirement of accreditation and must be reported to URAC on an annual basis. # NAME DESCRIPTION NUMERATOR DENOMINATOR
More informationOver 425 Members Strong
Quality Measurement 101: The Basics Camille Smith, MSW, MSPH Director, Member Education Karen Johnson, MS Senior Director, Quality Measurement October 8, 2015 2:00pm-3:00pm ET Over 425 Members Strong 2
More information